Analysis reveals clinicopathologic concordance in Alzheimer’s disease and frontotemporal lobar degeneration, indicating diagnosis challenges.
Objective Investigating antemortem diagnosis in cases of autopsy-confirmed neurodegenerative disease is critical to understand clinicopathologic concordance versus misdiagnosis. In addition, comorbid pathology can complicate clinicopathologic relationships. This study examined concordance between antemortem etiologic diagnoses (Alzheimer’s disease, AD; frontotemporal lobar degeneration, FTLD) and postmortem neuropathology (AD neuropathologic change, ADNC; FTLD; and comorbid ADNC/FTLD). Method We compared National Alzheimer's Coordinating Center clinical data at final visit before death in individuals from 3 autopsy groups: intermediate-to-high ADNC, FTLD, and comorbid ADNC/FTLD. Primary clinical (etiologic) diagnosis was based on available clinical, cognitive, and biomarker data. Results Of 919 individuals, 94 (age=84±10, 46%F) had comorbid ADNC/FTLD, 590 had ADNC only (age=84±11), and 235 had FTLD only (age=73±12). The FTLD-only group was younger at last visit and death (p’s<.001), while groups did not differ on other demographics or cognitive status. Within the comorbid group, 81% had cognitive impairment with the following presumed etiologies: 62% AD, 32% progressive supranuclear palsy, corticobasal degeneration, or other FTLD, and 7% with non-AD/FTLD etiologies. Within the ADNC-only group, 86% had cognitive impairment, with 82% presumed due to AD (concordant), and the remaining 18% misdiagnosed with other etiologies. For the FTLD-only group, 86% had cognitive impairment, with 74% presumed due to FTLD (concordant), and the remaining 26% misdiagnosed with other etiologies. Conclusion Etiological AD diagnosis was twice as likely as FTLD in cognitively-impaired individuals with comorbid ADNC/FTLD neuropathology on autopsy. Misdiagnosis was not uncommon in pure ADNC or FTLD, highlighting the often discrepant nature of clinicopathologic correlation which can lead to ineffective treatment and inaccurate prognosis.
No takes yet. Share an insight, caveat, or question.
Ross et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: